Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype

Omalizumab is a monoclonal antibody indicated for the treatment of severe uncontrolled asthma with an allergic phenotype. Its effectiveness could be influenced by clinical variables and single nucleotide polymorphisms (SNPs) in one or more of the genes involved in the mechanism of action and process...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojo-Tolosa, Susana, Sánchez-Martínez, José Antonio, Pineda-Lancheros, Laura Elena, Gálvez-Navas, José María, González-Gutiérrez, María Victoria, Jiménez-Gálvez, Gonzalo, Pérez-Ramírez, Cristina, Morales-García, Concepción, Jiménez-Morales, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139019/
https://www.ncbi.nlm.nih.gov/pubmed/37108192
http://dx.doi.org/10.3390/ijms24087029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139019/
https://www.ncbi.nlm.nih.gov/pubmed/37108192
http://dx.doi.org/10.3390/ijms24087029

Ejemplares similares